|
|
 |
|
Viewing report
|
|
|
|
Celldex Therapeutics, Inc. - SWOT Analysis
Datamonitor, Nov 2010, Pages: 20
The Celldex Therapeutics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. Celldex Therapeutics, Inc. - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Celldex Therapeutics (formerly known as Avant Immunotherapeutics) is a biotechnology company engaged in the discovery, development and commercialization of targeted immunotherapies. The company focuses on the use of tumor-specific targets and human monoclonal antibodies as precision delivered therapeutic agents for the treatment of cancer, infectious and inflammatory diseases. The company operates in the US and the UK. It is headquartered in Needham, Massachusetts and employed 90 people as of December 2009. The company recorded revenues of $15.2 million during the financial year (FY) ended December 2009, as compared to the revenues of $7.5 million in FY2008. The operating loss of the company was $36.9 million during FY2009, as compared to an operating loss of $48.8 million in FY2008. The net loss was $36.5 million in FY2009, as compared to a net loss of $47.5 million in FY2008.
Scope of the Report
- Provides all the crucial information on Celldex Therapeutics, Inc. required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Celldex Therapeutics, Inc. in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Celldex Therapeutics, Inc.
-Data is supplemented with details on Celldex Therapeutics, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Celldex Therapeutics, Inc.
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
|
|
|
|
